New drug PEEL-224 takes on advanced cancers in first human trial
Disease control
Recruiting now
This early study tests a new drug, PEEL-224, for safety and how well it fights tumors in about 65 people with advanced solid tumors that have not responded to standard treatments. The goal is to find the best dose and see if the drug can shrink tumors. Participants must have good…
Phase: PHASE1 • Sponsor: Peel Therapeutics Inc • Aim: Disease control
Last updated May 17, 2026 00:29 UTC